Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $10.3500 (0.98%) ($9.9000 - $10.5100) on Fri. Aug. 30, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.67% (three month average) | RSI | 59 | Latest Price | $10.3500(0.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.3% a day on average for past five trading days. | Weekly Trend | AUTL advances 1.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) DRIV(15%) IBB(14%) EWI(13%) IFRA(13%) IWC(13%) | Factors Impacting AUTL price | AUTL will decline at least -2.335% in a week (0% probabilities). VXX(-8%) VIXM(-7%) TLT(-6%) BWX(-2%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.335% (StdDev 4.67%) | Hourly BBV | 0 () | Intraday Trend | 1% | | | |
|
1 - 5 Day Possible Target | $-19.95(-292.75%) | Resistance Level | $11.16 | 5 Day Moving Average | $10.5(-1.43%) | 10 Day Moving Average | $10.61(-2.45%) | 20 Day Moving Average | $11.16(-7.26%) | To recent high | -51.1% | To recent low | 5.7% | Market Cap | $541m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |